VRDN-003

· Viridian Therapeutics, Inc.

Drug timelines are a Plus or Pro feature.

6 regulatory and trial events tracked for VRDN-003, covering 2025-09-30 to 2026-08-18. Get the full timeline:

Most recent: Clinical Trial Update: An Efficacy, Safety, and Tolerability Study of VRDN-003 in Participants With Active Thyroid Eye Disease (TED) [Phase 3]

See pricing